Seeking Alpha

  Nektar Therapeutics - NASDAQ

11/24/2014, 4:21 AM ET
  • reachmygoals1 | Send Message 31 Mar 2012

    Nektar's(NKTR) upcoming catalysts: * NKTR-102 - Phase 2 expansion top-line data in ovarian cancer (April) * NKTR-181 - Phase 2 start
      NKTR vs. ETF Alternatives
      Company Description
      Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States